Skip to content

Clinical trials

Ovarian Neoplasms trials in Italy

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Ovarian Neoplasms Country / region: Italy Clear all

256 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20034
20041
20054
20067
20073
20088
20096
20109
20117
20126
201310
20147
20156
20169
20178
201814
201913
202017
202126
202215
202316
202423
202518
202611

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed94
Recruiting64
Unknown status33
Active, not recruiting33
Terminated19
Not yet recruiting10
Withdrawn2
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Fondazione Policlinico Universitario Agostino Gemelli IRCCS34
AstraZeneca17
National Cancer Institute, Naples15
Catholic University of the Sacred Heart10
Hoffmann-La Roche10
IRCCS Azienda Ospedaliero-Universitaria di Bologna7
Merck Sharp & Dohme LLC7
Eli Lilly and Company6
European Organisation for Research and Treatment of Cancer - EORTC6
Novartis Pharmaceuticals5

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Ovarian Neoplasms256
Fallopian Tube Neoplasms47
Endometrial Neoplasms36
Breast Neoplasms32
Uterine Cervical Neoplasms23
Carcinoma, Non-Small-Cell Lung21
Carcinoma, Ovarian Epithelial21
Colorectal Neoplasms20
Neoplasms19
Pancreatic Neoplasms16

Trials

Showing 26 to 50 of 256. Each trial links to its page on Pharma Observatory.

156 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.